Paper · 33920587
The Potential of FGF-2 in Craniofacial Bone Tissue Engineering: A Review.
Novais A and 3 others. Cells, 2021. Cited by 54 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Potential of FGF-2 in Craniofacial Bone Tissue Engineering: A Review. Papers, record 33920587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33920587
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Face | Major topic |
| Fibroblast Growth Factor 2 | Major topic |
| Skull | Major topic |
| Tissue Engineering | Major topic |
| Animals | |
| Homeostasis | |
| Humans | |
| Models, Biological |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| URP2496 | Université de Paris | PubMed | ||
| 20-2020 | Fondation des gueules cassées | PubMed | ||
| PulpCell2014-2018 | Agence Nationale de la Recherche | PubMed | ||
| FDM202006011319 | Fondation pour la Recherche Médicale | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References254
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22,432,625 | Tissue engineering and regenerative medicine: history, progress, and challenges. | Annu Rev Chem Biomol Eng | 2011 | https://conductscience.org/library/papers/22432625 | PubMed |
| 2 | 1,696,268 | Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. | J Cell Biol | 1990 | https://conductscience.org/library/papers/1696268 | PubMed |
| 3 | 16,249,723 | Fibroblast growth factor-2 stimulates hyaluronan production by human dental pulp cells. | J Endod | 2005 | https://conductscience.org/library/papers/16249723 | PubMed |
| 4 | 14,565,596 | bFGF administration lowers the phosphate threshold for mineralization in bone marrow stromal cells. | Calcif Tissue Int | 2003 | https://conductscience.org/library/papers/14565596 | PubMed |
| 5 | 14,563,548 | Fibroblast growth factor signaling controlling osteoblast differentiation. | Gene | 2003 | https://conductscience.org/library/papers/14563548 | PubMed |
| 6 | 17,205,557 | Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. | J Orthop Res | 2007 | https://conductscience.org/library/papers/17205557 | PubMed |
| 7 | 11,276,432 | Fibroblast growth factors. | Genome Biol | 2001 | https://conductscience.org/library/papers/11276432 | PubMed |
| 8 | 29,942,929 | Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease. | J Endocr Soc | 2018 | https://conductscience.org/library/papers/29942929 | PubMed |
| 9 | 27,486,231 | Blood vessel formation and function in bone. | Development | 2016 | https://conductscience.org/library/papers/27486231 | PubMed |
| 10 | 23,465,883 | Extracellular modulation of Fibroblast Growth Factor signaling through heparan sulfate proteoglycans in mammalian development. | Curr Opin Genet Dev | 2013 | https://conductscience.org/library/papers/23465883 | PubMed |
1 to 10 of 254
See all 254 referencesCited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,698,179 | The Therapeutic Potential of Purmorphamine Across Disease Models. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42698179 | PubMed |
| 42,559,531 | Bioprinting of miRNA-Induced Spheroids for Vascularized, Heterocellular Bone Regeneration. | Chem Eng J | 2026 | https://conductscience.org/library/papers/42559531 | PubMed |
| 42,514,921 | Dual-Functional Gel-Based Delivery of Chitosan-Coated Gold Nanoparticles for Accelerated Bone Healing in Defect Models. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514921 | PubMed |
| 42,405,063 | Silk fibroin/nano-hydroxyapatite scaffolds with graphene oxide induce macrophage M2 polarization and enhance angiogenesis to facilitate bone repair. | RSC Adv | 2026 | https://conductscience.org/library/papers/42405063 | PubMed |
| 42,359,251 | RNA-seq analysis unveils differential gene expression patterns following intermittent hypoxia in the mandibular condyles of growing male rats. | Front Physiol | 2026 | https://conductscience.org/library/papers/42359251 | PubMed |
| 41,897,396 | The Degeneration Paradox: Severely Degenerated Cervical Nucleus Pulposus Cells Display Enhanced Mechanoplasticity Under Moderate Cyclic Tensile Strain. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897396 | PubMed |
| 41,583,576 | Role of FGF2 in promoting osteogenic differentiation for craniofacial bone regeneration. | Regen Eng Transl Med | 2025 | https://conductscience.org/library/papers/41583576 | PubMed |
| 41,553,860 | A retrospective cohort study comparing periodontal regeneration using fibroblast growth factor-2 versus autologous bone graft. | J Periodontol | 2026 | https://conductscience.org/library/papers/41553860 | PubMed |
| 41,476,752 | PRP-related biomaterials enhance bone and nerve repair. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41476752 | PubMed |
| 41,207,974 | Bone Marrow Mesenchymal Stromal Cell Osteogenesis is driven by Paracrine signals from Regulatory T Cell. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41207974 | PubMed |
1 to 10 of 42
See all 42 cited byGenes51
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ALPP | 250 | PubTator's text mining | https://conductscience.org/library/genes/250 | NCBI Gene |
| BGLAP | 632 | PubTator's text mining | https://conductscience.org/library/genes/632 | NCBI Gene |
| BMP1 | 649 | PubTator's text mining | https://conductscience.org/library/genes/649 | NCBI Gene |
| BMP2 | 650 | PubTator's text mining | https://conductscience.org/library/genes/650 | NCBI Gene |
| CALCA | 796 | PubTator's text mining | https://conductscience.org/library/genes/796 | NCBI Gene |
| DKK1 | 22,943 | PubTator's text mining | https://conductscience.org/library/genes/22943 | NCBI Gene |
| DMP1 | 1,758 | PubTator's text mining | https://conductscience.org/library/genes/1758 | NCBI Gene |
| DSPP | 1,834 | PubTator's text mining | https://conductscience.org/library/genes/1834 | NCBI Gene |
| FGF1 | 2,246 | PubTator's text mining | https://conductscience.org/library/genes/2246 | NCBI Gene |
1 to 10 of 51
See all 51 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33920587
GET https://conductscience.org/api/papers/v1/33920587/references?page=2